Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

TCMD PEER ANALYSIS

Tactile Systems Technology Inc — metric-by-metric comparison with peers and the industry median

TCMDTactile Systems Technology Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
TCMDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
TCMD+214.6%4DX+1,679.6%SN+4.6%ONCSM+203.3%COH-56.7%MEDTR-8.2%
Year-to-Date (YTD)
TCMD+9.9%4DX+10.9%SN-6.9%ONCSM-4.8%COH-50.3%MEDTR+0.3%
1-Year
Split-adjusted
TCMD+214.6%SIBN-4.3%CERS+113.0%CTKB+22.9%CLPT+53.8%INMD-3.7%
Year-to-Date (YTD)
TCMD+9.9%SIBN-10.3%CERS+59.2%CTKB-8.5%CLPT+31.6%INMD-0.6%

Key Metric Comparison

P/E

Lower is better
TCMD35.424DX—SN20.73ONCSM122.41COH24.27MEDTR596.83Median 26.82

ROE

Higher is better
TCMD9.6%4DX—SN12.1%ONCSM12.9%COH18.1%MEDTR0.2%Median -8.6%

Net Margin

Higher is better
TCMD5.9%4DX-3,684.6%SN10.1%ONCSM6.3%COH14.6%MEDTR0.2%Median -5.7%

Revenue Growth

Higher is better
TCMD17.2%4DX-26.0%SN—ONCSM39.1%COH2.0%MEDTR6.5%Median 7.4%

P/E

Lower is better
TCMD35.42SIBN—CERS—CTKB—CLPT—INMD10.71Median 26.82

ROE

Higher is better
TCMD9.6%SIBN-9.6%CERS-15.5%CTKB-20.9%CLPT-149.7%INMD13.6%Median -8.6%

Net Margin

Higher is better
TCMD5.9%SIBN-8.1%CERS-4.3%CTKB-36.2%CLPT-71.6%INMD23.3%Median -5.7%

Revenue Growth

Higher is better
TCMD17.2%SIBN16.8%CERS20.3%CTKB3.6%CLPT26.0%INMD-4.5%Median 7.4%

All Metrics

Valuation
MetricTCMD4DXSNONCSMCOHMEDTRInd. Median
P/E35.42—20.73●122.4124.27596.8326.82
P/B3.30-76.08●2.5013.364.321.082.50
EV/EBITDA15.88—9.94●25.4615.2010.9315.54
P/S2.09249.462.107.663.551.18●2.69
Financial Health
MetricTCMD4DXSNONCSMCOHMEDTRInd. Median
Current Ratio4.246.57●2.572.252.463.583.28
Debt/Equity7.0%-22.6%●62.9%35.0%22.1%1.0%44.7%
NetDebt/EBITDA-1.440.711.720.420.42-1.64●0.82
Profitability
MetricTCMD4DXSNONCSMCOHMEDTRInd. Median
Net Margin5.9%-3,684.6%10.1%6.3%14.6%●0.2%-5.7%
ROE9.6%—12.1%12.9%18.1%●0.2%-8.6%
ROA7.3%-264.3%6.1%8.0%12.4%●0.2%-6.4%
EBITDA Margin12.1%-818.8%25.6%30.6%●24.0%9.4%5.2%
Growth + Dividend
MetricTCMD4DXSNONCSMCOHMEDTRInd. Median
Rev. Growth17.2%-26.0%—39.1%●2.0%6.5%7.4%
NI Growth25.3%●———-6.8%-62.9%16.7%
Div. Yield——3.5%0.0%3.6%●1.1%1.1%
Payout——52.8%0.0%81.5%656.3%39.0%
Valuation
MetricTCMDSIBNCERSCTKBCLPTINMDInd. Median
P/E35.42————10.71●26.82
P/B3.304.349.431.8128.231.41●2.50
EV/EBITDA15.88—549.34——3.90●15.54
P/S2.09●3.772.862.9113.102.492.69
Financial Health
MetricTCMDSIBNCERSCTKBCLPTINMDInd. Median
Current Ratio4.249.99●1.634.695.798.803.28
Debt/Equity7.0%4.1%144.1%11.1%337.5%0.7%●44.7%
NetDebt/EBITDA-1.4422.9314.2310.20-1.18-5.17●0.82
Profitability
MetricTCMDSIBNCERSCTKBCLPTINMDInd. Median
Net Margin5.9%-8.1%-4.3%-36.2%-71.6%23.3%●-5.7%
ROE9.6%-9.6%-15.5%-20.9%-149.7%13.6%●-8.6%
ROA7.3%-7.1%-4.4%-15.9%-47.1%12.0%●-6.4%
EBITDA Margin12.1%-2.9%0.5%-10.8%-58.2%27.5%●5.2%
Growth + Dividend
MetricTCMDSIBNCERSCTKBCLPTINMDInd. Median
Rev. Growth17.2%16.8%20.3%3.6%26.0%●-4.5%7.4%
NI Growth25.3%●————-50.4%16.7%
Div. Yield——————1.1%
Payout——————39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TCMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.